So the administration of asiaticoside to depression-like mice restored the composition of the gut microbiota, could improve intestinal permeability and blood-brain barrier integrity, then could decrease the levels of IL-6, TNF-α, CRH, and CORT and increase hippocampal BDNF levels. Here, IL6 is linked to major depressive disorder.